Related Experiment Videos
. . . and losartan was no better than placebo
Journal of Human Hypertension
|October 12, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Urocortin 2 - a protective effect in hypertension?
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.
International journal of cardiology·2021
Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?
Hipertension y riesgo vascular·2015
Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
Journal of internal medicine·2009
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
Diabetic medicine : a journal of the British Diabetic Association·2007
beta-blocker use and diabetes symptom score: results from the GEMINI study.
Diabetes, obesity & metabolism·2007
The association between mobility and asleep blood pressure alterations in frail and non-frail adults 80 years and older.
Journal of human hypertension·2026
Beyond ad hoc home blood pressure monitoring: The need for standardisation and integration into primary care.
Journal of human hypertension·2026
Prevalence of hypertension in severe vs. non-severe COVID-19: a systematic review and meta-analysis.
Journal of human hypertension·2026
Triple drug antihypertensive single-pill combinations included as WHO essential medicines: an overview of efficacy, safety, and cost.
Journal of human hypertension·2026
Nontraumatic unilateral ureteral entrapment at the sacroiliac joint: A rare cause of obstructive uropathy.
Radiology case reports·2026
Evaluation of confirmatory data following the Article 12 MRL review for beta-cyfluthrin.
EFSA journal. European Food Safety Authority·2026
Comparing User-Written Codes for Performing Economic Evaluations in Stata.
PharmacoEconomics·2026